Skip to content
Clinical Trials – home
GermanyBack to Germany

Clinical trials in Flensburg – page 3

77 clinical trials in Flensburg, Germany. Every trial is listed in the EU Clinical Trials Register and updated daily.

GermanyOur site in GermanyKlinischeStudien.de(opens in a new tab)
Flensburg at a glance
77
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

77 trials in Flensburg

Open in trial search

Osteoporosis

Recruiting

Study on the Effects of Stopping Alendronic Acid in Patients with Osteoporosis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Alendronic Acid
  • Sponsor:Odense University Hospital

Renal failure

Recruiting

Study on Preventing Blood Infections in Hemodialysis Patients Using Amoxicillin/Clavulanic Acid or Clindamycin

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Amoxicillin
  • Sponsor:Region Sjaelland

Study on Fluid Removal Using Furosemide and Amiloride Hydrochloride in ICU Patients with Fluid Overload

Registered drug
Countries:CzechiaCzechia
  • Participants:18–64 years · 65+ years
  • Substances:Furosemide
  • Sponsor:Region Hovedstaden

Study of Adagrasib Alone and with Pembrolizumab for Patients with Advanced Non-Small Cell Lung Cancer with KRAS G12C Mutation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Study on Omeprazole and Cow's Milk-Free Diet for Treating Gastroesophageal Reflux Disease in Infants Under 1 Year

Registered drug
Countries:DenmarkDenmark
  • Participants:0–17 years
  • Substances:Omeprazole
  • Sponsor:Odense University Hospital

Study Comparing Conventional Therapy and Biologic Treatments for Early Rheumatoid Arthritis Using Hydroxychloroquine, Abatacept, and Azathioprine in Responsive Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Abatacept
  • Sponsor:Karolinska Institutet

Study of Iberdomide and Isatuximab for Maintenance Therapy in Patients with Newly Diagnosed Multiple Myeloma After Stem-Cell Transplantation

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Dexamethasone
  • Sponsor:Universitaetsklinikum Heidelberg AöR

Study of Sacituzumab Tirumotecan and Pembrolizumab for Patients with Triple-Negative Breast Cancer Post-Surgery

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Capecitabine
  • Sponsor:Merck Sharp & Dohme LLC

Study on Lowering INR to Reduce Bleeding in Patients with Mechanical Aortic Valves Using Warfarin, Acenocoumarol, and Phenprocoumon

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Acenocoumarol
  • Sponsor:Hamilton Health Sciences Corporation

Study on the Safety and Effectiveness of Warfarin for Patients with Atrial Fibrillation Undergoing Dialysis

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Warfarin Sodium
  • Sponsor:Region Hovedstaden

Study on Mifepristone and Letrozole for Treating Ectopic Pregnancy in Comparison to Methotrexate

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Letrozole
  • Sponsor:Karolinska Institutet

Study Comparing FDG-PET/CT and CT for Monitoring Treatment Response in Patients with Metastatic Breast Cancer Using Fludeoxyglucose (18F)

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Fludeoxyglucose (18F)
  • Sponsor:Odense University Hospital

Other cities in Germany

The busiest research cities in the country

All 505 cities in Germany

Clinical research in Flensburg

What the registry says about research in the country

01 Hematologic Malignancies

Extensive research focusing on Acute Myeloid Leukemia (AML) and novel combination therapies. Studies evaluating targeted treatments for patients with specific genetic mutations and those ineligible for intensive chemotherapy.

  • AML with genetic mutations
  • Multiple Myeloma treatments
  • Myelodysplastic Syndrome

Multiple innovative approaches being tested to improve survival rates and treatment outcomes.

02 Solid Tumors

Clinical trials examining new treatments for lung cancer and colorectal cancer, with a focus on targeted therapies and personalized medicine approaches.

  • Non-small Cell Lung Cancer
  • Colon Cancer Stage II
  • PD-L1 targeted therapies

Studies incorporating biomarker testing and molecular diagnostics for treatment selection.

03 Supportive Care

Research initiatives exploring quality of life improvements for cancer patients, including innovative symptom management approaches.

  • Palliative care interventions
  • Cannabinoid treatments
  • Symptom burden reduction

Focus on developing evidence-based supportive care strategies for oncology patients.

Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.